| scholarly article | Q13442814 |
| P2093 | author name string | Dong Shen | |
| Jun Su | |||
| Zhi-Li Liu | |||
| Wei-Dong Mao | |||
| Wen-Kai Xia | |||
| Qing-Feng Lin | |||
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 |
| Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer | Q33448971 | ||
| Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era | Q33558130 | ||
| A new prognostic score for elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: the prognostic role of blood monocyte and lymphocyte counts is absent | Q33945770 | ||
| Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. | Q34388117 | ||
| Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model | Q35128731 | ||
| Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. | Q35757467 | ||
| Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era. | Q36194582 | ||
| Etiologic heterogeneity among non-Hodgkin lymphoma subtypes | Q37003547 | ||
| Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options | Q37824825 | ||
| Relapsed/refractory diffuse large B-cell lymphoma | Q37967335 | ||
| Treatment of the elderly patient with diffuse large B cell lymphoma | Q37998553 | ||
| New developments in the management of diffuse large B-cell lymphoma | Q38003014 | ||
| Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer | Q38545138 | ||
| Prognostic role of peripheral blood lymphocyte/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis | Q41428549 | ||
| Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era. | Q43629612 | ||
| Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. | Q43686080 | ||
| Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients? | Q43754838 | ||
| The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era. | Q44098784 | ||
| Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era. | Q44404015 | ||
| The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy. | Q45287423 | ||
| Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma | Q45327559 | ||
| Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma | Q46420610 | ||
| Enhanced International Prognostic Index (NCCN-IPI), Charlson Comorbidity Index and absolute lymphocyte count as predictors for survival of elderly patients with diffuse large B cell lymphoma treated by immunochemotherapy. | Q48933646 | ||
| Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens. | Q53101266 | ||
| The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. | Q53153100 | ||
| Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma. | Q53497203 | ||
| P433 | issue | 6 | |
| P921 | main subject | B-cell lymphoma | Q4833719 |
| lymphocyte | Q715347 | ||
| diffuse large B-cell lymphoma | Q2626074 | ||
| P304 | page(s) | 558-565 | |
| P577 | publication date | 2016-05-04 | |
| P1433 | published in | FEBS Open Bio | Q27724062 |
| P1476 | title | Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis | |
| P478 | volume | 6 |
| Q92885765 | Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma |
| Q90077233 | Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma |
| Q38729502 | The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential |
Search more.